SCWorx Corp. (WORX) - Forward P/S Multiple

Corporate emblem and logo of SCWorx Corp (WORX)

SCWorx Corp. is creating deep software integration into closed clinic databases, establishing a barrier to entry for new players. The business's forward P/S reflects market value relative to expected sales, where the 0.60 mark serves as the current indicator. The steadfast trust of hospitals confirms its status as a reliable vendor. An impeccable reputation in supply chain management helps medical centers reduce costs.

WORX SCWorx: Market Cap to Future Revenue Ratio in the range 07/04/2022 - 11/13/2026

Financial and market metric breakdowns for SCWorx Inc (WORX)

- stock price and consensus target price:
Comprehensive company analysis:SCWorx (WORX)
Original product of scworx.com

With SCWorx Corp. currently focusing on supporting its existing software architecture without new breakthroughs, the projected P/S trend allows for a valuation of market capitalization relative to expected sales, eliminating reporting time lags. This indicator measures the ability of future cash flows to cover liabilities, while excessively high values on the chart signal an overvaluation of the asset amid R&D stagnation.

Competitors of SCWorx Corp. (WORX)

Veeva - Forward Price-to-Revenue Multiple|Forward Price to Sales DOCS|HealthEquity Corp - Forward P/S Multiple|Waystar Corp (WAY) - Forward Price-to-Revenue Multiple|CorVel Corporation (CRVL) - Price-to-Projected Revenue Ratio|Market Cap to Future Revenue Ratio priviahealth.com (PRVA)|Price-to-Projected Revenue Ratio Huron|CERT: Forward Price to Sales|Price-to-Projected Revenue Ratio Omnicell Corp (OMCL)|GDRX: Future Price to Revenue|Schrodinger, Inc. - Forward Price-to-Revenue Multiple|Market Cap to Expected Sales Ratio phreesia.com (PHR)|OMDA: Forward Price-to-Revenue Multiple|Evolent Health Inc (EVH) - Forward Price-to-Revenue Multiple|HealthStream Corp (HSTM) - Price-to-Projected Revenue Ratio|Market Cap to Future Revenue Ratio Definitive Corp (DH)|Price-to-Projected Revenue Ratio Consensus Cloud Solutions|AGL: Forward Price to Sales|Forward Price-to-Revenue Multiple ABSI (Absci Corporation)|So-Young International Inc - Market Cap to Projected Revenue|Forward P/S Multiple NRC (National Research Corporation)|Market Cap to Expected Sales Ratio USA Mobility (SPOK)|OPRX: Forward Price-to-Revenue Multiple|trubridge.com - Price to Expected Revenue Ratio|SLP (Simulations Plus) - Forward Price-to-Revenue Multiple|SOPHiA GENETICS - Forward Price to Sales|Price-to-Projected Revenue Ratio Health Catalyst, Inc|Forward Price-to-Revenue Multiple CareCloud Corp (CCLD)|Forward P/S Multiple RSSS|DLHC - Market Cap to Future Revenue Ratio|Forward P/S Multiple ONMD (OneMedNet)|SCNX: Market Cap to Projected Revenue|HCTI - Price-to-Projected Revenue Ratio|Market Cap to Expected Sales Ratio iSpecimen Inc. ISPC|BFRG: Forward P/S Multiple|Forward Price-to-Revenue Multiple msprecovery.com|Forward Price-to-Revenue Multiple ICCT|Forward Price-to-Revenue Multiple TRxADE HEALTH Inc (MEDS)|Price-to-Projected Revenue Ratio Orgenesis Corp (ORGS)|RCM - Market Cap to Future Revenue Ratio|Price-to-Projected Revenue Ratio Sharecare, Inc. SHCR|Forward Price to Sales STRM|SYRA: Forward Price-to-Revenue Multiple|AMEH (Apollo Medical Holdings) - Market Cap to Projected Revenue|MODN (Model N Corp) - Forward Price-to-Revenue Multiple|NextGen Healthcare Corp - Forward Price to Sales